Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.

Roland ArnitzMarkus SteinPetra BauerBarbara LanthalerHerbert JamnigSabine Scholl-BürgiKatharina Stempfl-Al-JazrawiHanno UlmerBernhard BaumgartnerSabine EmbacherSimon GeislerJohanna M GostnerBernhard MüllingerBeate KälzMarkus Nagl

Published in: Therapeutic advances in respiratory disease (2019)

Inhaled NCT is well tolerated as in other applications of different body regions. Side effects are mild, topical and transitory. The study was registered prospectively in the European Clinical Trials Database of the European Medicines Agency. The EudraCT number is 2012-003700-12.

Keyphrases

double blind
clinical trial
open label
placebo controlled
cystic fibrosis
phase ii
phase iii
randomized controlled trial
study protocol
drug induced